We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rii | LSE:RIN | London | Ordinary Share | GB0007383234 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8317I RII PLC 21 February 2005 February 21 2005 RII plc ("the company") Result of EGM RII shareholders approve EGM resolutions Shareholders in RII plc today approved all the resolutions for the company to raise #3.0million, to acquire BioPartners Limited ("BioPartners") and to change the name of the company to Minster Pharmaceuticals plc (Minster). Application has been made to the London Stock Exchange for the resultant enlarged share capital to be admitted to trading on AIM and dealings are expected to commence on Friday, 25th February 2005. Minster is developing compounds for the treatment and prevention of migraine and for the treatment of chronic schizophrenia. Paul Sharpe, who has been appointed Chairman and Chief Executive of Minster, said: " We are in a strong position to address the very large markets that exist for migraine and for schizophrenia and so to generate value for our shareholders as we move our compounds closer towards clinical use." Robert Stubbs, who is stepping down as Chairman of the Company but continuing as a non-executive director, said: "We are delighted to have acquired BioPartners and thank our shareholders for their support. We look forward to the future with confidence" ENDS For further information, please contact Cubitt Consulting Michael Henman 020 7367 5106 Minster Pharmaceuticals plc Dr Paul Sharpe Chairman/CEO 01799 506623 Minster Pharmaceuticals plc Robert Stubbs Director 020 7355 4071 Insinger de Beaufort Jeremy King Stephen Goschalk 020 7190 7000 This information is provided by RNS The company news service from the London Stock Exchange END REGTBMTTMMBTBBA
1 Year Rii Chart |
1 Month Rii Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions